RJFSA
AEMD icon

Raymond James Financial Services Advisors’s Aethlon Medical AEMD Stock Holding History

Raymond James Financial Services Advisors’s Portfolio AEMD Stock Details AEMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1
Closed -$19K – 2776
2018
Q1 		$19K Hold
1
– – ﹤0.01% 2498
2017
Q4 		$18K Buy
+1
New +$12.2K ﹤0.01% 2492

Other funds holding AEMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CFN
Cordasco Financial Network Naples, Florida $138M AUM 10.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
SAM
Shamrock Asset Management Dallas, Texas $128M AUM 2.65% 1-Year Est. Return

Raymond James Financial Services Advisors's AEMD Position: Q2 2018 in Review

Raymond James Financial Services Advisors sold out of Aethlon Medical (AEMD) in Q2 2018, closing a stake of 1 share — an estimated $19K sold.

Raymond James Financial Services Advisors first reported a position in AEMD in Q4 2017 and held it in 2 quarters. The position peaked at $19K in Q1 2018. 12 funds tracked by Wall St. Rank hold AEMD as of Q2 2018.

  • Raymond James Financial Services Advisors reported no remaining Aethlon Medical position as of Q2 2018 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 1 Aethlon Medical share in Q2 2018, an estimated $19K.
  • Raymond James Financial Services Advisors first reported a position in Aethlon Medical in Q4 2017 and held it in 2 quarters.
  • Raymond James Financial Services Advisors's Aethlon Medical position peaked at $19K in Q1 2018.
  • 12 funds tracked by Wall St. Rank held Aethlon Medical as of Q2 2018.

Based on Raymond James Financial Services Advisors's 13F filing for Q2 2018, filed 30 Jul 2018.